Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma.
Saved in:
| Title: | Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma. |
|---|---|
| Authors: | Seneviratne, Janith A.1,2 (AUTHOR), Ravindrarajah, Daenikka1,2 (AUTHOR), Carter, Daniel R.1,3 (AUTHOR), Zhai, Vicki1 (AUTHOR), Lalwani, Amit1 (AUTHOR), Krishan, Sukriti1,2 (AUTHOR), Balachandran, Anushree1 (AUTHOR), Ng, Ernest1,2 (AUTHOR), Pandher, Ruby1,2 (AUTHOR), Wong, Matthew1,2 (AUTHOR), Nero, Tracy L.4 (AUTHOR), Wang, Shudong5 (AUTHOR), Norris, Murray D.1,2,6 (AUTHOR), Haber, Michelle1,2 (AUTHOR), Liu, Tao1,2 (AUTHOR), Parker, Michael W.4,7 (AUTHOR), Cheung, Belamy B.1,2 (AUTHOR) bcheung@ccia.unsw.edu.au, Marshall, Glenn M.1,2,8 (AUTHOR) glenn.marshall@health.nsw.gov.au |
| Source: | Cancer Medicine. Nov2024, Vol. 13 Issue 21, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.70082 |
